Vista Pharmaceuticals Limited
VISTAPH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$369.31M
Close$
Share Statistics
| Market cap | $369.31 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.96 |
| Beta | 0.1 |
| Outstanding Shares | 61,551,907 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -3.21 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vista Pharmaceuticals Limited
30 employees
CEO: Dhananjaya Alli Vista Pharmaceuticals Ltd. specializes in the production and distribution of pharmaceutical goods. Its product line encompasses a diverse selection of generic medications, available as both over-the-counter and prescription items, delive...